
|Articles|July 1, 2016
- Pharmaceutical Executive-07-01-2016
- Volume 36
- Issue 7
Pharmaceutical Executive, July 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Transforming Technology: The Future of the CIO in the Life Sciencesabout 9 years ago
Keeper of the Name: Bayer's Habib Dableabout 9 years ago
Worlds Beyond the Clinicabout 9 years ago
'PRIME' Time for Medicines in the EUabout 9 years ago
Pill Countersover 9 years ago
Country Report: Italy, Part 2Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Ypsomed Announces New U.S.-Based Manufacturing Site in North Carolina
2
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
3
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
4
AstraZeneca to Announce Deal with Trump Administration: Report
5